CTOs on the Move

Janux Therapeutics

www.januxrx.com

 
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.januxrx.com
  • 10955 Vista Sorrento Parkway Suite 200
    San Diego, CA USA 92130
  • Phone: 858.751.4493

Executives

Name Title Contact Details
Reza Farahmand
Senior Director of Information Technology Profile

Funding

Janux Therapeutics raised $125M on 04/20/2021

Similar Companies

Adverum

Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.

CardioVascular BioTherapeutics

CardioVascular BioTherapeutics, Inc. is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stem Cell Therapeutics

Stem Cell Therapeutics Corp. is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ALERT Life Sciences Computing

ALERT Life Sciences Computing is a Reston, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.